Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis
Biological disease-modifying anti-rheumatic drugs (bDMARDs) are widely used for the treatment of chronic inflammatory rheumatic diseases. Since the introduction of tumor necrosis factor alpha (TNF-) inhibitors, the treatment of rheumatoid arthritis has been revolutionized. The approach of targeting...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
State Scientific Center of Dermatovenereology and Cosmetology,
2021-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|